GR00016-A |
2268 |
2268 |
FGR |
np |
1.87 |
none |
|
no |
|
Wnt/beta-catenin pathway regulation |
Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling. |
James et al. |
2009 |
19471023 |
Cell line |
RKO |
Wnt/beta-catenin pathway reporter |
Luminescence |
rp |
Selected genes |
siRNA |
Z-score |
> 2 |
|
GR00053-A |
2268 |
NM_005248 |
FGR |
np |
sp |
none |
|
no |
|
Genome stability |
A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. |
Paulsen et al. |
2009 |
19647519 |
Cell line |
HeLa |
gamma-H2AX phosphorylation and DNA content |
Fluorescence |
siARRAY human genome siRNA library |
Genome-wide |
siRNA |
p-value |
Complex criteria |
Confidence groupings from 4 to 1 (highest level of confidence in group 4) |
GR00054-A |
2268 |
NM_005248 |
FGR |
np |
1.09 |
none |
|
no |
|
Combinatorial effect with paclitaxel |
Synthetic lethal screen identification of chemosensitizer loci in cancer cells. |
Whitehurst et al. |
2007 |
17429401 |
Cell line |
NCI-H1155 |
Viability (synthetic lethal) |
ATP level |
# G-005000-01 |
Genome-wide |
siRNA |
Paclitaxel/control ratio |
Complex criteria |
Additional information about 87 high-confidence hits |
|
2268 |
2268 |
FGR |
np |
np |
Decreased cell migration |
|
yes |
deconvoluted validated siRNAs: 0/2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00055-A-3 |
2268 |
2268 |
FGR |
np |
np |
Increased cell migration |
|
no |
|
Epithelial cell migration (3) |
Identification of genes that regulate epithelial cell migration using an siRNA screening approach. |
Simpson et al. |
2008 |
19160483 |
Cell line |
MCF-10A overexpressing ERBB2 |
Cell migration and viability |
Microscopy and fluorescence |
SMARTpool siRNA library and MAR library |
Selected genes |
siRNA |
Area score and Alamar score |
Complex criteria |
|
GR00056-A |
2268 |
NM_005248 |
FGR |
np |
1.041 |
none |
|
no |
|
Melanogenesis |
Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. |
Ganesan et al. |
2008 |
19057677 |
Cell line |
MNT-1 |
Melanin protein expression and viability |
Absorbance and luminescence |
rp |
Genome-wide |
siRNA |
Normalized absorbance ratio |
> 2 standard deviations below mean |
Additional information about a secondary screen (retest to determine false-positive rate) |
GR00057-A-1 |
2268 |
NM_005248 |
FGR |
M-003135-02 |
0 |
none |
|
no |
|
Wnt/beta-catenin pathway regulation (1) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Z-score |
> 4 |
Screen without Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00057-A-2 |
2268 |
NM_005248 |
FGR |
M-003135-02 |
sp |
none |
|
no |
|
Wnt/beta-catenin pathway regulation (2) |
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. |
Tang et al. |
2008 |
18621708 |
Cell line |
HeLa |
Wnt pathway reporter |
Luminescence |
Human siArray siRNA library |
Genome-wide |
siRNA |
Complex, SP |
Complex criteria |
Screen with Wnt3A stimulation. Additional information about secondary screens (Dharmacon and Qiagen libraries). |
GR00093-A-0 |
2268 |
|
FGR |
np |
2.4 |
Increased apoptosis |
|
no |
|
Apoptosis pathway |
Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. |
MacKeigan et al. |
2005 |
15864305 |
Cell line |
HeLa |
Apoptosis (histone-DNA fragmentation) |
ELISA |
Custom-made library (Qiagen) |
|
siRNA |
Fold increase |
> |
|
GR00095-A |
2268 |
NM_005248 |
FGR |
np |
np |
none |
|
|
|
p53 pathway components |
A large-scale RNAi screen in human cells identifies new components of the p53 pathway |
Berns et al. |
2004 |
15042092 |
Cell line |
BJ-TERT-tsLT fibroblasts |
Proliferation |
Colony-forming cell assay |
Nki library |
Genome-wide |
shRNA |
np |
np |
|
GR00096-A |
2268 |
NM_005248 |
|
NM_005248 siRNA1, NM_005248 siRNA2 |
sp |
Decreased nuclei size in G2M |
|
no |
|
Cell-cycle regulation |
Genome-wide functional analysis of human cell-cycle regulators. |
Mukherji et al. |
2006 |
17001007 |
Cell line |
U2OS |
Cell number and nuclei size |
Fluorescence |
Custom-made |
Genome-wide and druggable genes |
siRNA |
Complex, sp |
np |
Additional information about a secondary screen |
GR00098-A-1 |
2268 |
ENSG00000000938 |
FGR |
ENSG00000000938 |
sp |
none |
|
no |
|
Cell division (1) |
Genome-scale RNAi profiling of cell division in human tissue culture cells. |
Kittler et al. |
2007 |
17994010 |
Cell line |
HeLa |
Cell number and DNA content |
Laser scanning cytometry |
rp |
Genome-wide |
esiRNA |
Complex, sp |
Complex criteria |
|
GR00110-A-0 |
2268 |
|
FGR |
shFGR-385 |
28.1 |
Increased mitotic index |
|
no |
|
Cell cycle |
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. |
Moffat et al. |
2006 |
16564017 |
Cell line |
HT29 |
Mitotic index |
High content (microscopy) |
TRC shRNA library |
|
shRNA |
Mitotic index |
> |
|
GR00114-A |
2268 |
|
FGR |
np |
-2.11 |
none |
|
|
72% |
Combinatorial effect with Poly (ADPâ€ribose)â€polymeraseâ€1 (PARP) |
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. |
Turner et al. |
2008 |
18388863 |
Cell line |
CAL51 |
Viability |
Luminescence |
siARRAY SMARTpool |
Kinases |
siRNA |
Z-score |
< |
Growth rates (%) for vehicle-alone experiments are given in the comment field. |
GR00123-A |
2268 |
NM_005248 |
FGR |
101192, 101193, 101191 |
np |
none |
|
|
|
Combinatorial effect with nutlin-3 |
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors |
Brummelkamp et al. |
2006 |
16474381 |
Cell line |
MCF-7 |
Viability |
Fluoresence |
Nki library |
Genome-wide |
shRNA |
log2 ratio |
np |
|
GR00133-A-1 |
2268 |
2268 |
FGR |
np |
0.106807 |
none |
|
no |
|
Salmonella enterica subspecies 1 serovar Typhimurium invasion (1) |
RNAi screen of Salmonella invasion shows role of COPI in membrane targeting of cholesterol and Cdc42. |
Misselwitz et al. |
2011 |
21407211 |
Cell line |
HeLa |
Gentamycin protection invasion assay |
Fluorescence |
Druggable genome library V2.0 |
Druggable genes |
siRNA |
log2 median |
Complex criteria |
|
GR00141-A |
2268 |
NM_005248 |
FGR |
np |
np |
none |
|
no |
|
T cell chemotaxis |
Synaptotagmin-mediated vesicle fusion regulates cell migration. |
Colvin et al. |
2010 |
20473299 |
Cell line |
SupT1 |
Cell migration |
Fluorescence |
shRNA Library |
Kinases, phosphatases and selected genes |
shRNA |
Chemotactic index |
> 1 standard deviation from plate mean by at least 2 shRNAs |
|
GR00149-A-1 |
2268 |
2268 |
FGR |
1468 |
109.67 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
2268 |
2268 |
FGR |
1468 |
82.89 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
2268 |
2268 |
FGR |
1562 |
-7.45 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
2268 |
2268 |
FGR |
1562 |
-45.76 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
2268 |
2268 |
FGR |
145142 |
-22.23 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00149-A-1 |
2268 |
2268 |
FGR |
145142 |
-4.21 |
none |
|
no |
|
Ciliogenesis and cilium length (1) |
Functional genomic screen for modulators of ciliogenesis and cilium length. |
Kim et al. |
2010 |
20393563 |
Cell line |
htRPE |
Smoothed protein expression |
Fluorescence |
Human druggable genome siRNA library V3.1 |
Druggable genes |
siRNA |
Normalized percent inhibition |
> 1.5 OR < -1.5 standard deviations from mean |
|
GR00151-A-1 |
2268 |
ENSG00000000938 |
FGR |
np |
-0.666 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. |
Słabicki et al. |
2010 |
20613862 |
Cell line |
HeLa |
(HR-DSBR) DR-GFP reporter |
Flow cytometry |
Custom-made |
Genome-wide |
esiRNA |
Z-score |
< -2 OR > 2 |
|
GR00154-A |
2268 |
NM_005248 |
FGR |
np |
0.12 |
Decreased viability with TRAIL |
1 μg/ml TRAIL |
no |
|
TRAIL-induced apoptosis |
Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. |
Aza-Blanc et al. |
2003 |
14527409 |
Cell line |
HeLa |
Viability |
Alamar Blue |
np |
Kinases and selected genes |
siRNA |
Sensitivity ratio |
Top 20 AND bottom 20 |
|
GR00155-A |
2268 |
2268 |
FGR |
FGR_1, FGR_2, FGR_3 |
np |
none |
|
no |
|
Aryl hydrocarbon receptor (AhR) transduction pathway regulation |
RNAi-based screening identifies kinases interfering with dioxin-mediated up-regulation of CYP1A1 activity. |
Gilot et al. |
2011 |
21479225 |
Cell line |
MCF-7 |
TCDD-induced CYP1A1-related EROD activity and cell viability |
Fluorescence and methylene blue |
MISSION siRNA Human Kinase Panel library |
Kinases |
siRNA |
Z-score |
Top 150 for > |
|
GR00180-A-1 |
2268 |
2268 |
FGR |
PL-50001 |
0.899 |
none |
|
no |
|
Hepatitis C virus replication (1) |
A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. |
Tai et al. |
2009 |
19286138 |
Cell line |
Huh7/Rep-Feo |
HCV replicon RNA copy number |
Luminescence |
siARRAY Human Genome siRNA Library |
Genome-wide |
siRNA |
q-value |
Complex criteria |
|
GR00184-A-1 |
2268 |
NM_005248 |
FGR |
M-003135-02 |
-1.13345974355907 |
none |
|
no |
|
Self-renewal and pluripotency in human embryonic stem cells (1) |
A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. |
Chia et al. |
2010 |
20953172 |
Cell line |
hESC H1 |
POU5F1 protein expression |
Fluorescence |
SMARTpool siRNA library |
Genome-wide |
siRNA |
Z-score |
< -2 |
|
GR00193-A-1 |
2268 |
2268 |
FGR |
FGR |
0.565370665714268 |
none |
|
yes |
|
Therapeutic kinase targets in neuroblastoma (1) |
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. |
Cole et al. |
2011 |
21289283 |
Cell line |
EBC1 |
Substrate adherent cell growth |
rp |
Kinase siGenome library |
Kinases |
siRNA |
Relative growth |
0.5 standard deviations below mean |
|
GR00193-A-2 |
2268 |
2268 |
FGR |
FGR |
1.08098820187813 |
none |
|
yes |
|
Therapeutic kinase targets in neuroblastoma (2) |
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. |
Cole et al. |
2011 |
21289283 |
Cell line |
KELLY |
Substrate adherent cell growth |
rp |
Kinase siGenome library |
Kinases |
siRNA |
Relative growth |
0.5 standard deviations below mean |
|
GR00193-A-3 |
2268 |
2268 |
FGR |
FGR |
0.924617027791476 |
none |
|
yes |
|
Therapeutic kinase targets in neuroblastoma (3) |
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. |
Cole et al. |
2011 |
21289283 |
Cell line |
SKNAS |
Substrate adherent cell growth |
rp |
Kinase siGenome library |
Kinases |
siRNA |
Relative growth |
0.5 standard deviations below mean |
|
GR00193-A-4 |
2268 |
2268 |
FGR |
FGR |
1.4345921578634 |
none |
|
no |
|
Therapeutic kinase targets in neuroblastoma (4) |
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. |
Cole et al. |
2011 |
21289283 |
Cell line |
NLF |
Substrate adherent cell growth |
rp |
Kinase siGenome library |
Kinases |
siRNA |
Relative growth |
0.5 standard deviations below mean |
|
GR00196-A-1 |
2268 |
ENSG00000000938 |
|
np |
sp |
none |
|
no |
|
TP53 interactions (1) |
A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly. |
Krastev et al. |
2011 |
21642980 |
Cell line |
HCT116 ( wildtype and TP53 knockout) |
TP53 protein expression and viability |
Fluorescence |
rp |
Genome-wide |
esiRNA |
Complex, sp |
Complex criteria |
|
GR00197-A-1 |
2268 |
2268 |
FGR |
M-003135-02 |
-0.212525485 |
none |
|
no |
|
Human papillomavirus oncogene expression regulation (1) |
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. |
Smith et al. |
2010 |
20133580 |
Cell line |
C33A/BE2/18LCR c4 |
HPV18 LCR reporter activity |
Luminescence |
Human siGENOME SMARTpool library |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Phenotype strength according to Z-scores: weak: 2 - 3; moderate: 3 - 5; strong: > 5 |
GR00210-A |
2268 |
2268 |
FGR |
np |
sp |
none |
|
no |
|
Focal adhesion formation |
Multiparametric analysis of focal adhesion formation by RNAi-mediated gene knockdown. |
Winograd-Katz et al. |
2009 |
19667130 |
Cell line |
HeLa |
paxillin protein expression |
Fluorescence |
SMARTpool siARRAY siRNA Libraries |
Kinases, phosphatases and selected genes |
siRNA |
Z-score |
> 3.5 OR < -3.5 |
|
GR00221-A-1 |
2268 |
|
FGR |
TRCN0000001593 |
-0.95 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (1) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MCF-7 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-1 |
2268 |
|
FGR |
TRCN0000001594 |
-0.39 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (1) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MCF-7 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-1 |
2268 |
|
FGR |
TRCN0000001596 |
-0.2 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (1) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MCF-7 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-1 |
2268 |
|
FGR |
TRCN0000001595 |
1.27 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (1) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MCF-7 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
2268 |
|
FGR |
TRCN0000001597 |
-3.56 |
Decreased viability |
|
yes |
essential gene |
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
2268 |
|
FGR |
TRCN0000001593 |
-2.11 |
Decreased viability |
|
yes |
essential gene |
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
2268 |
|
FGR |
TRCN0000001595 |
-0.01 |
none |
|
yes |
essential gene |
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
2268 |
|
FGR |
TRCN0000001596 |
1.21 |
none |
|
yes |
essential gene |
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-2 |
2268 |
|
FGR |
TRCN0000001594 |
1.24 |
none |
|
yes |
essential gene |
Proliferation of cells with active beta-catenin (2) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-231 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-3 |
2268 |
|
FGR |
TRCN0000001593 |
-0.58 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (3) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-453 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-3 |
2268 |
|
FGR |
TRCN0000001594 |
-0.4 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (3) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-453 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-3 |
2268 |
|
FGR |
TRCN0000001595 |
0.17 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (3) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-453 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-3 |
2268 |
|
FGR |
TRCN0000001596 |
1.16 |
none |
|
yes |
|
Proliferation of cells with active beta-catenin (3) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
MDA-MB-453 |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-4 |
2268 |
|
FGR |
TRCN0000001596 |
2.05 |
none |
|
no |
|
Proliferation of cells with active beta-catenin (4) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
T47D |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-4 |
2268 |
|
FGR |
TRCN0000001593 |
-1.21 |
Decreased viability |
|
no |
|
Proliferation of cells with active beta-catenin (4) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
T47D |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-4 |
2268 |
|
FGR |
TRCN0000001594 |
0.53 |
none |
|
no |
|
Proliferation of cells with active beta-catenin (4) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
T47D |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
GR00221-A-4 |
2268 |
|
FGR |
TRCN0000001595 |
2.03 |
none |
|
no |
|
Proliferation of cells with active beta-catenin (4) |
CK1epsilon is required for breast cancers dependent on beta-catenin activity. |
Kim et al. |
2010 |
20126544 |
Cell line |
T47D |
Viability |
Luminescence |
TRC shRNA Library |
Kinases |
shRNA |
B-score |
< -1 |
Essential gene: gene with B-score < -1 for > |
|
2268 |
NM_005248 |
FGR |
np |
0.865302 |
none |
|
no |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00230-A-2 |
2268 |
|
FGR |
np |
strong/medium |
Decreased senescence-associated beta-galactosidase protein expression after pRB stimulation |
|
no |
|
pRB-induced cell cycle regulation (2) |
A kinase shRNA screen links LATS2 and the pRB tumor suppressor. |
Tschöp et al. |
2011 |
21498571 |
Cell line |
SaOS2-TR-pRB |
Senescence-associated beta-galactosidase protein expression |
Colorimetrics |
Lentiviral shRNA library |
Kinases |
shRNA |
Intensity and percentage of stained cells |
Strong for > |
|
GR00231-A |
2268 |
NM_005248 |
FGR |
M-003135-02 |
-0.313 |
none |
|
yes |
|
Cell proliferation |
Time-resolved human kinome RNAi screen identifies a network regulating mitotic-events as early regulators of cell proliferation. |
Zhang et al. |
2011 |
21765947 |
Cell line |
HeLa |
Viability |
Electrical impedance |
Human siARRAY - Protein Kinase and Cell Cycle libraries |
Kinases and selected genes |
siRNA |
Z-score |
< -1.96 OR > 1.96 |
Additional information about cell titer blue cell viability screen |
GR00234-A-1 |
2268 |
NM_005248 |
FGR |
np |
sp |
Decreased Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) infection |
|
yes |
|
Hepatitis C virus (HCV) infection (1) |
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. |
Lupberger et al. |
2011 |
21516087 |
Cell line |
Huh7 |
Hepatitis C Virus pseudoparticles (HCVpp; H77; genotype 1a) protein expression |
Luminescence |
Human Kinase RNAi Set V2.0 |
Kinases |
siRNA |
Complex, sp |
Complex criteria |
|
GR00234-A-2 |
2268 |
NM_005248 |
FGR |
np |
sp |
Decreased cell–culture–derived Hepatitis C virus (HCVcc; Luc–Jc1) infection |
|
yes |
3 of 4 siRNAs validated |
Hepatitis C virus (HCV) infection (2) |
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. |
Lupberger et al. |
2011 |
21516087 |
Cell line |
Huh7.5.1 |
Cell–culture–derived Hepatitis C virus (HCVcc; Luc–Jc1) and vesicular stomatitis virus pseudoparticles (VSVpp) protein expression |
Luminescence |
np |
Kinases |
siRNA |
Complex, sp |
Complex criteria |
|
|
2268 |
|
FGR |
np |
np |
Decreased viability in esophageal squamous lineage |
|
no |
esophageal squamous: no filter, KS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00236-A-1 |
2268 |
2268 |
FGR |
M-003135-02 |
1.35654816911259 |
none |
|
no |
|
Homologous recombination DNA double-strand break repair (HR-DSBR) (1) |
A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. |
Adamson et al. |
2012 |
22344029 |
Cell line |
DR-U2OS |
(HR-DSBR) DR-GFP reporter and DNA content |
Fluorescence |
Human siGENOME siRNA (G-005000-05) |
Genome-wide |
siRNA |
Relative HR ratio |
< ~0.4 OR > 1.88 |
Cutoff values correspond 2 standard deviations from the screen-wide mean |
GR00240-S-1 |
2268 |
NM_005248 |
FGR |
M-003135-02 |
2.79 |
none |
|
yes |
|
TRAIL-induced apoptosis (1) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Z-score |
> 4 |
Author-submitted data |
GR00240-S-2 |
2268 |
NM_005248 |
FGR |
M-003135-02 |
-1.66 |
none |
|
no |
Z-score 1.377 |
TRAIL-induced apoptosis (2) |
A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. |
Kranz and Boutros |
2014 |
24442637 |
Cell line |
U251MG |
Viability (synthetic lethal) |
Luminescence |
SMART-pool siRNA |
Genome-wide |
siRNA |
Differential score |
> 3.6 AND viability Z-score < 4 |
Author-submitted data. Z-scores from viability screen (1) are considered in score interpretation for this screen. |
GR00242-A-1 |
2268 |
NM_005248 |
FGR |
np |
sp |
none |
|
no |
|
Selective autophagy regulation (1) |
Image-based genome-wide siRNA screen identifies selective autophagy factors. |
Orvedahl et al. |
2011 |
22020285 |
Cell line |
HeLa/GFP-LC3 |
Sindbis virus (SIN) capsid SIN-mCherry.capsid and autophagosome GFP–LC3 protein expression |
Fluorescence |
siGenome |
Genome-wide |
siRNA |
Z-score |
Complex criteria |
|
GR00247-A-1 |
2268 |
|
FGR |
np |
sp |
none |
|
|
rank: 16944 |
Regulation of FOXO1 nuclear localization (1) |
Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. |
Senapedis et al. |
2011 |
21460183 |
Cell line |
U2OS |
EGFP-FOXO1a protein expression and DNA content |
Fluorescence |
Human Genome library |
Genome-wide |
siRNA |
Complex, sp |
Complex criteria |
|
GR00248-A |
2268 |
NM_005248 |
FGR |
FGR_siRNA1 |
-0.06 |
none |
|
|
|
Human cytomegalovirus (HCMV) strain AD169 replication |
Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. |
Terry et al. |
2012 |
22315427 |
Cell line |
MRC5 |
Human cytomegalovirus (HCMV) IE1 protein expression |
Fluorescence |
Mission siRNA Human Kinase Panel |
Kinases |
siRNA |
Z-score |
> |
|
GR00248-A |
2268 |
NM_005248 |
FGR |
FGR_siRNA2 |
0.553 |
none |
|
|
|
Human cytomegalovirus (HCMV) strain AD169 replication |
Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. |
Terry et al. |
2012 |
22315427 |
Cell line |
MRC5 |
Human cytomegalovirus (HCMV) IE1 protein expression |
Fluorescence |
Mission siRNA Human Kinase Panel |
Kinases |
siRNA |
Z-score |
> |
|
GR00248-A |
2268 |
NM_005248 |
FGR |
FGR_siRNA3 |
1.725 |
none |
|
|
|
Human cytomegalovirus (HCMV) strain AD169 replication |
Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. |
Terry et al. |
2012 |
22315427 |
Cell line |
MRC5 |
Human cytomegalovirus (HCMV) IE1 protein expression |
Fluorescence |
Mission siRNA Human Kinase Panel |
Kinases |
siRNA |
Z-score |
> |
|
GR00249-S |
2268 |
2268 |
FGR |
J-003135-10 |
-0.86778 |
none |
|
no |
number of cells compared to control (%): 82.63 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
2268 |
2268 |
FGR |
M-003135-03 |
0.75525 |
none |
|
no |
number of cells compared to control (%): 54.69 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
2268 |
2268 |
FGR |
s5185 |
0.7701 |
none |
|
no |
number of cells compared to control (%): 78.57 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
2268 |
2268 |
FGR |
s5186 |
-1.00369 |
none |
|
no |
number of cells compared to control (%): 85.25 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00249-S |
2268 |
2268 |
FGR |
s5187 |
0.3402 |
none |
|
no |
number of cells compared to control (%): 66.71 |
Vaccinia virus (VACV) infection |
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesis. |
Sivan et al. |
2013 |
23401514 |
Cell line |
HeLa |
Vaccinia virus VACV IHD-J/GFP protein expression and DNA content |
Fluorescence |
Silencer Select Version 4, siGENOME SMARTpool and OnTargetPlus |
Genome-wide |
siRNA |
Z-score |
> |
Author-submitted data. Primary screen. Decreased viability phenotype if number of cells compared to control < 50 %. |
GR00253-A |
2268 |
NM_005248 |
FGR |
np |
0.241 |
none |
|
|
|
hepcidin regulation |
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. |
Mleczko-Sanecka et al. |
2014 |
24385536 |
Cell line |
Huh7 |
hepcidin::fluc mRNA expression |
Luminescence |
siGenome siARRAY SMARTpool |
Genome-wide |
siRNA |
Z-score |
> |
Cutoff < |
GR00255-A-1 |
2268 |
2268 |
FGR |
TRCN0000001593, TRCN0000001594, TRCN0000001595, TRCN0000001596, TRCN0000001597 |
0.323033436 |
none |
|
|
|
Negative genetic interactions (1) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 BLM-/- and HCT116 BLM+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-2 |
2268 |
2268 |
FGR |
TRCN0000001593, TRCN0000001594, TRCN0000001595, TRCN0000001596, TRCN0000001597 |
0.498314903 |
none |
|
|
|
Negative genetic interactions (2) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.0 |
HCT116 MUS81-/- and HCT116 MUS81+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-3 |
2268 |
2268 |
FGR |
TRCN0000001593, TRCN0000001594, TRCN0000001595, TRCN0000001596, TRCN0000001597 |
-0.149824889 |
none |
|
|
|
Negative genetic interactions (3) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTEN-/- and HCT116 PTEN+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-4 |
2268 |
2268 |
FGR |
TRCN0000001593, TRCN0000001594, TRCN0000001595, TRCN0000001596, TRCN0000001597 |
-0.541827948 |
none |
|
|
|
Negative genetic interactions (4) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -1.2 |
HCT116 PTTG1-/- and HCT116 PTTG1+/+ cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00255-A-5 |
2268 |
2268 |
FGR |
TRCN0000001593, TRCN0000001594, TRCN0000001595, TRCN0000001596, TRCN0000001597 |
0.364578983 |
none |
|
|
|
Negative genetic interactions (5) |
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. |
Vizeacoumar et al. |
2013 |
24104479 |
Cell line |
HCT116 |
shRNA abundance |
Microarray |
np |
Genome-wide |
shRNA |
differential Gene Activity Ranking Profile (dGARP) |
< -0.8 |
HCT116 KRASG13D/- and HCT116 KRAS+/- cells used. Cutoff corresponds to p-value < 0.05. Additional information about a secondary screen (genetic interactions with Cetuximab/Erbitux in LIM1215 cells) |
GR00256-A |
2268 |
NM_005248 |
FGR |
np |
sp |
none |
|
|
|
Kinase-mediated spindle orientation |
ABL1 regulates spindle orientation in adherent cells and mammalian skin. |
Matsumara et al. |
2012 |
22252550 |
Cell line |
HeLa |
beta-tubulin protein expression and DNA content |
Fluorescence |
Silencer Kinase siRNA library (AM80010V3) |
Kinases |
siRNA |
Complex, sp |
Complex criteria |
HeLa cells stably expressing GFP-H2B (HeLa-GH2B) used. Additional information about secondary screens. |
GR00293-A |
2268 |
|
FGR |
np |
0.518 |
none |
|
|
|
Combinatorial effect with paclitaxel |
Mechanisms Promoting Escape from Mitotic Stress−Induced Tumor Cell Death |
Sinnott et al. |
2014 |
24860162 |
Cell line |
HCC366 |
Viability |
Luminescence |
Thermo-Fisher |
Genome-wide |
siRNA |
Z-score |
< -2.5 |
Final hits according to the author are indicated in the comment. |
GR00300-A |
2268 |
|
FGR |
TRCN0000001593, TRCN0000199582, TRCN0000001596, TRCN0000199350, TRCN0000001597, TRCN0000001594, TRCN0000001595, TRCN0000199653, TRCN0000197132, TRCN0000199966 |
0 |
none |
|
|
|
Combinatorial effect with RAF inhibitor PLX4720 |
A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. |
Whittaker et al. |
2013 |
23288408 |
Cell line |
A375 |
shRNA abundance |
Sequencing |
TRC |
Genome-wide |
shRNA |
Number of shRNAs ranked Top1000 |
> 2 |
The A375 cell line used here harbours the BRAF V600E mutation and is therefore sensitive to RAF inhibitors. |
GR00303-A |
2268 |
NM_005248 |
FGR |
np |
-2.65 |
none |
|
|
|
Clear cell renal cell carcinoma (ccRCC) survival regulation |
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target |
Gerlinger et al. |
2012 |
22362593 |
Cell line |
VHL-deficient RCC4 |
Proliferation and Viability |
Fluorescence |
np |
Genome-wide |
siRNA |
Z-score |
< |
In the phenotype data duplicates were in the original document, which have been removed. |
GR00310-A-1 |
2268 |
2268 |
FGR |
np |
0.15 |
none |
|
|
|
Sindbis virus (SINV) infection (1) |
Genome-Wide RNAi Screen Identifies Novel Host Proteins Required for Alphavirus Entry |
Ooi et al. |
2013 |
24367265 |
Cell line |
U2OS |
Sindbis virus (SINV) reporter |
Luminescence |
Ambion Silencer V3 |
Genome-wide |
siRNA |
Z-score |
< -3 OR > 2 |
|
|
2268 |
2268 |
FGR |
np |
41.7 |
none |
|
|
98,7% viability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00313-A |
2268 |
NM_005248 |
FGR |
np |
0.21 |
none |
|
|
|
TNF-alpha pathway regulation |
A Genome-Wide RNA Interference Screen Identifies Caspase 4 as a Factor Required for Tumor Necrosis Factor Alpha Signaling. |
Nickles et al. |
2012 |
22733992 |
Cell line |
HEK293T |
NFkappaB pathway reporter |
Luminescence |
Qiagen |
Genome-wide |
siRNA |
Z-score |
< |
Additional filters were a reduction in firefly luciferase levels by at least 50% compared to the mean of the experiment and a concomitant reduction of renilla luciferase expression of not more than 30%. |
GR00318-A |
2268 |
2268 |
FGR |
np |
1.305 |
none |
|
|
siRNA set: kinase |
Huntingtin toxicity |
A Genome-Scale RNA–Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington’s Disease |
Miller et al. |
2012 |
23209424 |
Cell line |
HEK293T |
Caspase 3/7 activity |
Fluorescence |
Dharmacon |
Selected genes |
siRNA |
Sum of normalized caspase 3/7 activity mean and standard error |
< 0.683 |
HEK293T cells were cotransfected with mutant Huntingtin fused to GFP (Htt1-558141Q-GFP). |
GR00327-A |
2268 |
4451 |
FGR |
CLL-H-010122 |
0.6492890196334342 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00327-A |
2268 |
2268 |
ACAD9 |
CLL-H-000360 |
-1.7017649859294206 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00327-A |
2268 |
2268 |
ACAD9 |
CLL-H-000359 |
-0.46505739680079455 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00327-A |
2268 |
4451 |
FGR |
CLL-H-010120 |
0.49089755349694125 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00327-A |
2268 |
2268 |
ACAD9 |
CLL-H-000357 |
0.18479285207891116 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00327-A |
2268 |
2268 |
ACAD9 |
CLL-H-000361 |
-1.4120208317914764 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00327-A |
2268 |
4451 |
FGR |
CLL-H-010123 |
-1.0489285994952395 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00327-A |
2268 |
4451 |
FGR |
CLL-H-010124 |
-0.7653837153291404 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00327-A |
2268 |
2268 |
ACAD9 |
CLL-H-000358 |
0.23965247500146183 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00327-A |
2268 |
4451 |
FGR |
CLL-H-010121 |
0.12264677695978714 |
none |
|
|
|
Tumor formation |
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation |
Wolf et al. |
2013 |
24292671 |
Cell line |
SUM-149 |
shRNA abundance |
Next-generation sequencing |
Decipher library module 1 |
Selected genes |
shRNA |
Z-score |
> 2.24 |
Genes were scored as hit if at least 2 shRNAs scored as hit, see comment. |
GR00342-S-1 |
2268 |
|
FGR |
M-003135-02 |
-0.7716708201497018 |
none |
|
|
|
Viability of Mesenchymal Stem Cells (MSC) (1) |
Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening |
Erdmann et al. |
2015 |
26120366 |
Primary cells |
Bone marrow derived MSC |
Viability |
Luminescence |
Kinase siGENOME SMARTpool library |
Kinases and phosphatases |
siRNA |
Z-score |
> |
Donor 1, MSC preparation 1 (MSC1a) |
GR00342-S-2 |
2268 |
|
FGR |
M-003135-02 |
-1.3750272894943505 |
none |
|
|
|
Viability of Mesenchymal Stem Cells (MSC) (2) |
Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening |
Erdmann et al. |
2015 |
26120366 |
Primary cells |
Bone marrow derived MSC |
Viability |
Luminescence |
Kinase siGENOME SMARTpool library |
Kinases and phosphatases |
siRNA |
Z-score |
> |
Donor 1, MSC preparation 2 (MSC1b) |
GR00342-S-3 |
2268 |
|
FGR |
M-003135-02 |
-1.5273421418728015 |
Decreased viability |
|
|
|
Viability of Mesenchymal Stem Cells (MSC) (3) |
Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening |
Erdmann et al. |
2015 |
26120366 |
Primary cells |
Bone marrow derived MSC |
Viability |
Luminescence |
Kinase siGENOME SMARTpool library |
Kinases and phosphatases |
siRNA |
Z-score |
> |
Donor 2, MSC preparation 1 (MSC2) |
GR00343-S |
2268 |
2268 |
FGR |
TRCN0000001594 |
0.8999999999999986 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
2268 |
2268 |
FGR |
TRCN0000001596 |
-0.8975000000000009 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
2268 |
2268 |
FGR |
TRCN0000001597 |
0.3650000000000011 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
2268 |
2268 |
FGR |
TRCN0000001595 |
1.295 |
none |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00343-S |
2268 |
2268 |
FGR |
TRCN0000001593 |
-2.0975 |
shRNA abundance <= 25% |
|
|
|
Lentiviral shRNA "Achilles Heel" screen |
Inhibition of the mitochondrial protease, ClpP, as a therapeutic strategy for human acute myeloid leukemia |
Cole et al. |
2015 |
26058080 |
Cell line |
K562 |
shRNA abundance |
Fluorescence |
Lentiviral shRNA library |
Genome-wide |
shRNA |
Log2 ratio |
< |
Comparison of day 21 vs. day 0 abundance data |
GR00356-A-1 |
2268 |
NM_005248 |
FGR |
np |
0.65 |
none |
|
|
|
Clathrin-mediated endocytosis |
Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. |
Pelkmans et al. |
2005 |
15889048 |
Cell line |
HeLa |
Vesicular stomatitis virus (VSV) infection (rVSV–GFP expression) |
Fluorescence |
Ambion |
Kinases |
siRNA |
Relative infection index (RII) |
< |
The cutoff was < 0.4 OR > 2.5 if the gene also scored in the additional screen "Caveolin- and lipid raft-mediated endocytosis" using simian virus 40 (SV40). |
GR00356-A-2 |
2268 |
NM_005248 |
FGR |
np |
0.5790768479364511 |
none |
|
|
|
Caveolin- and lipid raft-mediated endocytosis |
Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. |
Pelkmans et al. |
2005 |
15889048 |
Cell line |
HeLa |
Simian virus 40 (SV40) infection (SV40 large T-antigen expression) |
Fluorescence |
Ambion |
Kinases |
siRNA |
Relative infection index (RII) |
< |
The cutoff was < 0.4 OR > 2.5 if the gene also scored in the additional screen "Clathrin-mediated endocytosis" using vesicular stomatitis virus (VSV). |
GR00356-A-3 |
2268 |
NM_005248 |
FGR |
np |
np |
toxic |
|
|
|
Endocytosis regulation |
Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. |
Pelkmans et al. |
2005 |
15889048 |
Cell line |
HeLa |
Transferrin (Tfn) uptake and trafficking |
Fluorescence |
Ambion |
Kinases |
siRNA |
np |
np |
|
GR00360-A-1 |
2268 |
ENSG00000000938 |
FGR |
1468 |
1.1144 |
Strongly decreased CFP-tsO45G cell surface transport |
|
|
|
Secretory transport (1) |
Genome-wide RNAi screening identifies human proteins with a regulatory function in the early secretory pathway |
Simpson et al. |
2012 |
22660414 |
Cell line |
HeLa Kyoto |
CFP-tsO45G cell surface transport |
Fluorescence |
Ambion |
Genome-wide |
siRNA |
Deviation score |
< - 1 OR > 0.75 (mild: 0.75 - 1.0; strong: > 1.0) |
For validation screen see Secretory transport (2). |
GR00363-A |
2268 |
2268 |
FGR |
SI00074473, 1652, 1468, esi5, SI00074494, SI02634807, 1562, SI03057047 |
sp |
Increased transferrin (TF) endocytosis |
|
|
strong |
Endocytosis regulation |
Systems survey of endocytosis by multiparametric image analysis. |
Collinet et al. |
2010 |
20190736 |
Cell line |
HeLa |
Transferrin (TF) and epidermal growth factor (EGF) subcellular localisation, DNA content |
Fluorescence |
Ambion, Qiagen and esiRNA library (Kittler et al.) |
Genome-wide |
siRNA |
Complex, sp |
Complex criteria |
Two hit categories: "strong" (maximum of Prob Chi2, Prob Chi2 EGF, Prob Chi2 Tfn > 0.95) and "weak but specific" (maximum of Prob Chi2, Prob Chi2 EGF, Prob Chi2 Tfn < 0.95 but Phenoscore > 0.95). Additional information about secondary screens with kinase and phospatase libraries. |
GR00368-A |
2268 |
2268 |
FGR |
|
0.76 |
Decreased viability ratio |
|
|
wt viability: 0,74 |
Combinatorial effect with E-Cadherin |
Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin–Deficient Cells |
Telford et al. |
2015 |
25777964 |
Cell line |
MCF10A |
Viability (synthetic lethal) |
Luminescence |
Dharmacon |
Genome-wide |
siRNA |
CDH1(-/-)/wt viability ratio |
< |
MCF10A wild type viability higher-or-equal to 50% was considered as additional cutoff (values noted in "comment" section). |
|
2268 |
2268 |
FGR |
|
0.04999999999999999 |
none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00371-A-1 |
2268 |
2268 |
FGR |
|
0.187733688839 |
none |
|
|
Dharmacon |
Nanog expression in absence of bFGF and TGFbeta |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-2 |
2268 |
FGR |
2268 |
|
-0.196945444005 |
none |
|
|
Dharmacon |
Nanog expression in presence of TGFbeta inhibitor |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-3 |
2268 |
2268 |
FGR |
|
1.04070640022 |
none |
|
|
Dharmacon |
Nanog expression in presence of MEK inhibitor |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-4 |
2268 |
2268 |
FGR |
|
-0.177878295181 |
none |
|
|
Dharmacon |
Nanog expression in presence of PI3K inhibitor |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00371-A-5 |
2268 |
2268 |
FGR |
|
0.793454355212 |
none |
|
|
Dharmacon |
Nanog expression in presence of retinoic acid |
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways |
Gonzales et al. |
2015 |
26232226 |
Cell line |
NANOG-GFP H1 hESC |
NANOG expression |
Fluorescence |
Dharmacon and Ambion |
Selected genes |
siRNA |
Z-score |
>1,25 OR >1,5 [in at least two replicates] |
Z-score shown is an average of the z-scores from the three replicates performed for each gene. In the "Comment" field, the siRNA library used for each particular gene is noted. |
GR00376-A-1 |
2268 |
2268 |
FGR |
|
0.248541842 |
none |
|
|
|
Mitigators of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "high dose", ≈EC90, 13 ng/ml. Cutoff was derived from data submitted to Pubchem (ID 1117281). Reagent sequences but no ID |
GR00376-A-2 |
2268 |
2268 |
FGR |
|
0.415509516 |
none |
|
|
|
Sensitizers of SS1P-induced immunotoxicity |
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity |
Pasetto et al. |
2015 |
25713356 |
Cell line |
KB cells |
Viability |
Luminescence |
Ambion Silencer Select Version 4 |
Genome-wide |
siRNA |
RSA P-value |
<0.001 |
SS1P was applied in a "low dose", ≈EC30, 3 ng/ml. Cutoff was derived from data submitted to PubChem (ID 1117281). Reagent sequences but no ID |
GR00378-A |
2268 |
|
FGR |
|
-0.50649159 |
none |
|
|
|
Poliovirus vaccine production |
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game |
van der Sanden et al. |
2015 |
26581994 |
Cell line |
HEp-2C |
Infection with Attenuated Poliovirus |
ELISA |
Dharmacon |
Genome-wide |
siRNA |
Z-score |
> |
For infection, a single lot of the attenuated Sabin type 2 poliovirus was used for the screen. Gene IDs were not provided, only the gene name/symbol |
|
2268 |
NM_005248 |
FGR |
|
33.872 |
none |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GR00386-A-1 |
2268 |
2268 |
FGR |
|
103.430370631406 |
none |
|
|
|
NOD2 stimulation by MDP |
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. |
Warner et al. |
2014 |
25170077 |
Cell line |
HEK293 stably expressing NOD2 |
Viability |
Luminescence |
Dharmacon |
Genome-wide |
siRNA |
Percentage growth |
Decreased: <70, increased: >120 |
Reagent IDs not provided |
GR00386-A-2 |
2268 |
2268 |
FGR |
|
-24.1 |
none |
|
|
|
MDP-induced IL-8 secretion |
A genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretion. |
Warner et al. |
2014 |
25170077 |
Cell line |
HEK293 stably expressing NOD2 |
IL-8 secretion |
ELISA |
Dharmacon |
Genome-wide |
siRNA |
Percent inhibition of IL-8 secretion |
Increased: <-300, Decreased: >60 |
Concentration of IL-8 was measured from cell supernatants by sandwich ELISA. IL-8 values (pg/ml) were normalized to IL-8 secreted in cells treated with RIPK2-specific siRNA (100% inhibition) and non-targeting siRNA (0% inhibition). Secondary validating screen assessed 554 genes whose silencing affected MDP-induced IL-8 secretion in the primary screen. Final validated IL-8 regulators (positive or negative) are listed in the comments column. Reagent IDs not provided |